The Formation of Intermediate Product I in a Purified System The Role of Factor IX or of its Precursor and of a Hageman Factor-PTA Fraction
- 31 December 1960
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 6 (02) , 224-234
- https://doi.org/10.1055/s-0038-1654555
Abstract
1. The role of two clot promoting fractions isolated from either plasma or serum is studied in a purified system for the generation of intermediate product I in which the serum is replaced by factor X and the investigated fractions. 2. Optimal generation of intermediate product I is possible in the purified system utilizing fractions devoid of factor IX one-stage activity. Prothrombin and thrombin are not necessary in this system. 3. The fraction containing factor IX or its precursor, no measurable activity by the one-stage assay method, controls the yield of intermediate product I. No similar fraction can be isolated from haemophilia B plasma or serum. 4. The Hageman factor — PTA fraction shortens the lag phase of intermediate product I formation and has no influence on the yield. This fraction can also be prepared from haemophilia B plasma or serum.Keywords
This publication has 5 references indexed in Scilit:
- Purification of Factor IX or its Precursor Isolation of a Hageman-PTA FractionThrombosis and Haemostasis, 1961
- Clotting Factor X. Physiologic and Physico-Chemical PropertiesExperimental Biology and Medicine, 1955
- A Modification of the Thromboplastin Generation TestActa Haematologica, 1954
- Physiology and Pathology of Blood CoagulationActa Haematologica, 1951
- Sur un nouveau facteur de la coagulation du sang, le facteur VIIHelvetica Chimica Acta, 1951